Reference health

Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase

https://doi.org/10.1007/s00018-015-1902-6
CiteStamped reference-health badge
1 of 53 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted by the publisher10.1042/BJ20131478
The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+–Cl− co-transporters
The 52 checked references that resolve
resolves10.1097/CAD.0b013e3283609ec1
Chemotherapy in metastatic renal cell carcinoma today? A systematic review
resolves10.1016/j.clindermatol.2012.08.016
Chemotherapy in the management of advanced cutaneous malignant melanoma
resolves10.1634/theoncologist.2010-0190
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
resolves10.1111/bjd.12698
Major therapeutic developments and current challenges in advanced melanoma
resolves10.1056/NEJMoa1103782
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
resolves10.1016/S0140-6736(12)60868-X
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
resolves10.1016/j.ejca.2012.11.019
Resistance to BRAF-targeted therapy in melanoma
resolves10.1016/j.ctrv.2013.09.003
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
resolves10.1586/era.12.81
Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science
resolves10.1016/j.ctrv.2012.01.003
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
resolves10.1016/j.ctrv.2012.06.010
What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?
resolves10.1002/ijc.28023
Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors
resolves10.1152/ajpcell.00102.2011
Ion channels and tranporters in cancer. 2. Ion channels and the control of cancer cell migration
resolves10.1098/rstb.2013.0109
Ion channels and transporters in the development of drug resistance in cancer cells
resolves10.1021/np200906s
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
resolves10.1016/j.bbagen.2013.02.008
Natural products: A continuing source of novel drug leads
resolves10.1021/cr900019j
Impact of Natural Products on Developing New Anti-Cancer Agents
resolves10.1016/j.phytochem.2003.11.006
Studies on structure–activity relationship of sphaeropsidins A–F, phytotoxins produced by Sphaeropsis sapinea f. sp. cupressi
resolves10.1021/np500258r
Diplopimarane, a 20<i>-nor-ent</i>-Pimarane Produced by the Oak Pathogen <i>Diplodia quercivora</i>
resolves10.1016/j.phytochem.2006.12.017
Anti-Candida metabolites from endophytic fungi
resolves10.1021/np2000864
Smardaesidins A–G, Isopimarane and 20-<i>nor</i>-Isopimarane Diterpenoids from Smardaea sp., a Fungal Endophyte of the Moss Ceratodon purpureus
resolves10.1016/j.phytol.2012.08.011
Evaluation of in vitro anticancer activity of sphaeropsidins A–C, fungal rearranged pimarane diterpenes, and semisynthetic derivatives
resolves10.1038/sj.jid.5700869
Galectin-1 Knockdown Increases Sensitivity to Temozolomide in a B16F10 Mouse Metastatic Melanoma Model
resolves10.1016/j.yexcr.2009.07.021
KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility
resolves10.1093/jnci/81.14.1088
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm
resolves10.1021/jm300542e
Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity
resolves10.1021/jm400287v
New 5-Aryl-1<i>H</i>-imidazoles Display in Vitro Antitumor Activity against Apoptosis-Resistant Cancer Models, Including Melanomas, through Mitochondrial Targeting
resolves10.1016/j.canlet.2009.02.048
The Na+/K+-ATPase is the Achilles Heel of multi-drug-resistant cancer cells
resolves10.1152/ajplung.00041.2003
Activation of K<sup>+</sup>channels: an essential pathway in programmed cell death
resolves10.1007/s00232-005-0836-6
Volume-sensitive Chloride Channels Involved in Apoptotic Volume Decrease and Cell Death
resolves10.1016/S1095-6433(01)00424-X
Apoptosis, cell volume regulation and volume-regulatory chloride channels
resolves10.1007/s10495-012-0716-3
Early-phase occurrence of K+ and Cl− efflux in addition to Ca2+ mobilization is a prerequisite to apoptosis in HeLa cells
resolves10.1152/ajpcell.1999.276.5.C995
Physiological significance of volume-regulatory transporters
resolves10.1113/jphysiol.2014.275529
Novel determinants of the neuronal Cl<sup>−</sup> concentration
resolves10.1159/000335843
Ion Channels Involved in Cell Volume Regulation: Effects on Migration, Proliferation, and Programmed Cell Death in Non Adherent EAT Cells and Adherent ELA Cells
resolves10.1136/jcp.2005.033100
Furosemide reverses multidrug resistance status in bladder cancer cells in vitro
resolves10.1159/000339047
Inhibition of Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>–</sup>Cotransporter isoform 1 Accelerates Temozolomidemediated Apoptosis in Glioblastoma Cancer Cells
resolves10.1113/jphysiol.2010.190769
Kinase regulation of Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>−</sup>cotransport in primary afferent neurons
resolves10.1152/physiolgenomics.2001.5.3.119
VHL tumor suppressor regulates Cl<sup>−</sup>/HCO<sub>3</sub><sup>−</sup>exchange and Na<sup>+</sup>/H<sup>+</sup>exchange activities in renal carcinoma cells
resolves10.1021/bi00092a014
Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: Further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein
resolves10.1021/bi00202a021
Novel Cl--Dependent Intracellular pH Regulation in Murine MDR 1 Transfectants and Potential Implications
resolves10.1021/bi00189a028
Transfection of mu MDR 1 Inhibits Na+-Independent Cl-/-HCO3 Exchange in Chinese Hamster Ovary Cells
resolves10.1152/ajpcell.00654.2008
Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels
resolves10.1007/s11010-007-9619-y
Anion exchanger inhibitor DIDS induces human poorly-differentiated malignant hepatocellular carcinoma HA22T cell apoptosis
resolves10.1007/s11010-009-0051-3
Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells
resolves10.1016/j.bbrc.2003.09.200
HNF1α upregulates the human AE2 anion exchanger gene (SLC4A2) from an alternate promoter
resolves10.3389/fphys.2013.00233
Cell volume regulation in epithelial physiology and cancer
resolves10.1158/0008-5472.CAN-09-4666
Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 Reduces Glioma Invasion
resolves10.1186/1476-4598-13-31
WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration
resolves10.1152/ajpcell.00203.2011
With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume
resolves10.1186/1471-2415-11-33
DPOFA, a Cl-/HCO3 -exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium
resolves10.1074/jbc.M109.014217
Studies on the DIDS-binding Site of Monocarboxylate Transporter 1 Suggest a Homology Model of the Open Conformation and a Plausible Translocation Cycle
The 2 references without a DOI — listed, not checked
no DOI — not checkedLee AH, Tannock IF (1998) Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res 58:1901–1908
no DOI — not checkedPogorevici A, Velciov SM, Secrii RV (2007) The molecular and physiopathological mechanisms involved in response reduction to chronic diuretics therapy. TMJ 57:58–67
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/s00018-015-1902-6"><img src="https://citestamp.com/citestamped/10.1007/s00018-015-1902-6/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/s00018-015-1902-6/badge.svg)](https://citestamp.com/citestamped/10.1007/s00018-015-1902-6)